The following represents disclosure information provided by faculty of the educational and scientific sessions. The Committee have reviewed all presented disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Fruquintinib plus paclitaxel versus paclitaxel as second-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma (FRUTIGA): A randomized, multicenter, double-blind, placebo-controlled, phase 3 study.
 
Rui-Hua Xu
 
Employment - No Relationships to Disclose
 
Leadership - No Relationships to Disclose
 
Stock and Other Ownership Interests - No Relationships to Disclose
 
Honoraria - No Relationships to Disclose
 
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; BeiGene; Bristol-Myers Squibb; HenRui; Junshi Biosciences; KYM Biosciences; Merck Serono; Roche
 
Speakers' Bureau - No Relationships to Disclose
 
Research Funding - No Relationships to Disclose
 
Patents, Royalties, Other Intellectual Property - No Relationships to Disclose
 
Expert Testimony - No Relationships to Disclose
 
Travel, Accommodations, Expenses - No Relationships to Disclose
 
Other Relationship - No Relationships to Disclose
 
(OPTIONAL) Uncompensated Relationships - No Relationships to Disclose
 
(OPTIONAL) Open Payments Link - No Relationships to Disclose